GMRE Stock Price, Global Medical REIT Inc Quote, Chart

Market Summary

USD8.91+0.02

Delayed

0.22%

GMRE Stock Price

View Fullscreen

GMRE RSI Chart

GMRE Valuation

Market Cap

584.4M

Price/Earnings (Trailing)

26.71

Price/Sales (Trailing)

4.18

Price/Free Cashflow

8.73

GMRE Price/Sales (Trailing)

GMRE Profitability

Return on Equity

3.66%

Return on Assets

1.73%

Free Cashflow Yield

11.46%

GMRE Fundamentals

GMRE Revenue

Revenue (TTM)

139.9M

Rev. Growth (Yr)

-3.07%

Rev. Growth (Qtr)

6.54%

GMRE Earnings

Earnings (TTM)

21.9M

Earnings Growth (Yr)

6.49%

Earnings Growth (Qtr)

319.96%

Breaking Down GMRE Revenue

Last 7 days

0.2%

Last 30 days

10.5%

Last 90 days

-7.0%

Trailing 12 Months

1.8%

How does GMRE drawdown profile look like?

GMRE Financial Health

Current Ratio

0.16

GMRE Investor Care

Dividend Yield

9.43%

Dividend/Share (TTM)

0.84

Shares Dilution (1Y)

0.09%

Diluted EPS (TTM)

0.23

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	139.9M	0	0	0
2023	141.6M	144.3M	144.4M	141.0M
2022	120.5M	125.9M	131.3M	137.3M
2021	99.4M	105.6M	110.5M	115.9M
2020	77.2M	82.4M	89.3M	93.7M
2019	56.8M	60.5M	64.7M	70.7M
2018	37.3M	43.1M	48.7M	53.2M
2017	11.6M	17.2M	23.6M	30.3M
2016	2.9M	4.2M	5.7M	8.2M
2015	1.9M	2.0M	2.0M	2.1M
2014	0	0	380.4K	1.1M

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Global Medical REIT Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Jan 30, 2023	moore roscoe m jr	acquired	-	-	7,412	-
Jan 10, 2023	moore roscoe m jr	sold	-48,956	9.7913	-5,000	-
Mar 29, 2022	moore roscoe m jr	acquired	-	-	5,000	-
Mar 04, 2022	cole henry	bought	19,999	15.5396	1,287	-
Mar 03, 2022	busch jeffrey	bought	31,100	15.55	2,000	chairman, president and ceo
Aug 19, 2021	busch jeffrey	bought	15,010	15.01	1,000	chairman, president and ceo
Mar 08, 2021	busch jeffrey	bought	24,167	13.81	1,750	chairman, president and ceo
Aug 12, 2020	marston ronald	bought	26,600	13.3	2,000	-
Aug 07, 2020	busch jeffrey	bought	133,900	13.39	10,000	chairman, president and ceo
Mar 12, 2020	cole henry	bought	19,978	10.8581	1,840	-

Which funds bought or sold GMRE recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 16, 2024	CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	reduced	-5.15	-183,366	543,384	-%
May 16, 2024	JANE STREET GROUP, LLC	sold off	-100	-484,204	-	-%
May 16, 2024	Tidal Investments LLC	added	5.79	-47,929	240,616	-%
May 16, 2024	Creekmur Asset Management LLC	reduced	-80.8	-77,953	13,904	-%
May 16, 2024	B. Riley Wealth Advisors, Inc.	added	31.00	46,519	781,863	0.02%
May 15, 2024	WEDBUSH SECURITIES INC	reduced	-65.25	-528,000	200,000	0.01%
May 15, 2024	STATE STREET CORP	reduced	-6.72	-5,926,490	16,797,400	-%
May 15, 2024	AE Wealth Management LLC	sold off	-100	-115,902	-	-%
May 15, 2024	DEUTSCHE BANK AG\	added	25.51	-2,875	268,564	-%
May 15, 2024	Quarry LP	new	-	23,923	23,923	-%

Are Funds Buying or Selling GMRE?

Are funds buying GMRE calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own GMRE

No. of Funds

Unveiling Global Medical REIT Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	vanguard group inc	9.36%	6,137,137	SC 13G/A
Jan 25, 2024	blackrock inc.	8.0%	5,241,267	SC 13G/A
Feb 09, 2023	vanguard group inc	9.79%	6,416,884	SC 13G/A
Jan 31, 2023	blackrock inc.	7.7%	5,035,110	SC 13G/A
Feb 03, 2022	blackrock inc.	7.6%	4,863,718	SC 13G
Feb 10, 2021	vanguard group inc	9.01%	4,343,493	SC 13G/A
Jan 29, 2021	blackrock inc.	7.1%	3,410,573	SC 13G/A
Mar 06, 2020	vanguard group inc	10.00%	4,290,304	SC 13G/A
Feb 11, 2020	vanguard group inc	9.86%	4,231,145	SC 13G
Feb 07, 2020	blackrock inc.	6.1%	2,602,565	SC 13G

Recent SEC filings of Global Medical REIT Inc

View All Filings

Date Filed	Form Type	Document
May 16, 2024	4	Insider Trading
May 16, 2024	4	Insider Trading
May 16, 2024	4	Insider Trading
May 16, 2024	4	Insider Trading
May 16, 2024	4	Insider Trading
May 16, 2024	8-K	Current Report
May 08, 2024	10-Q	Quarterly Report
May 07, 2024	8-K	Current Report
Apr 05, 2024	424B5	Prospectus Filed
Apr 05, 2024	8-K	Current Report

Peers (Alternatives to Global Medical REIT Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
AMT	90.9B	11.2B	13.13%	1.87%	46.04	8.11	3.63%	50.79%
CCI	44.7B	6.8B	10.57%	-9.74%	32.06	6.53	-2.39%	-16.60%
AVB	28.3B	2.8B	9.91%	13.04%	29.6	10.08	5.72%	-6.47%
ARE	21.7B	3.0B	6.63%	6.21%	110.61	7.35	10.44%	-73.79%
AMH	13.5B	1.6B	6.12%	9.11%	31.9	8.3	8.93%	11.87%
REG	11.3B	1.4B	6.30%	4.57%	30.12	8.22	10.48%	-2.93%
BXP	9.9B	3.3B	9.08%	28.09%	51.64	3	4.82%	-75.15%
MID-CAP
FRT	8.5B	1.2B	5.40%	14.57%	35.59	7.38	5.48%	-38.69%
SLG	3.4B	892.3M	6.62%	140.10%	-6.71	3.85	-5.33%	-307.54%
MAC	3.4B	878.0M	1.11%	67.10%	-9.8	3.82	2.35%	-290.60%
SMALL-CAP
AAT	1.4B	444.1M	12.17%	21.82%	20.36	3.15	3.54%	8.91%
AIV	1.2B	198.2M	6.70%	-0.84%	-7.55	6.02	-43.33%	-308.08%
MFA	1.1B	650.2M	7.51%	2.13%	36.77	1.73	27.93%	140.31%
NYMT	572.0M	285.4M	-8.06%	-36.92%	-4.15	2	11.05%	83.70%
IVR	459.4M	277.2M	15.74%	-12.95%	-56.03	1.66	25.89%	94.64%

Global Medical REIT Inc News

Latest updates

Global Medical REIT Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	6.5%	35.00	33.00	36.00	36.00	36.00	36.00	35.00	34.00	32.00	30.00	30.00	28.00	27.00	25.00	25.00	22.00	22.00	20.00	18.00	17.00	15.00
Operating Expenses	4.0%	33.00	32.00	33.00	35.00	35.00	34.00	32.00	30.00	28.00	26.00	25.00	24.00	24.00	22.00	35.00	20.00	19.00	18.00	16.00	14.00	13.00
S&GA Expenses	-100.0%	-	4.00	4.00	4.00	4.00	4.00	4.00	4.00	4.00	4.00	4.00	4.00	4.00	4.00	4.00	2.00	2.00	2.00	2.00	2.00	2.00
Interest Expenses	-1.3%	7.00	7.00	7.00	8.00	8.00	8.00	7.00	5.00	5.00	5.00	5.00	5.00	5.00	5.00	5.00	4.00	4.00	5.00	5.00	4.00	4.00
Net Income	320.0%	2.00	1.00	5.00	14.00	2.00	2.00	10.00	4.00	4.00	5.00	5.00	4.00	3.00	3.00	-9.58	2.00	3.00	3.00	2.00	2.00	2.00
Net Income Margin	1.4%	0.16*	0.15*	0.16*	0.20*	0.13*	0.15*	0.18*	0.15*	0.16*	0.16*	0.14*	0.00*	-	-	-	-	-	-	-	-	-
Free Cashflow	-21.1%	14.00	18.00	17.00	18.00	16.00	18.00	18.00	23.00	16.00	17.00	19.00	18.00	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	-0.3%	1,264	1,268	1,303	1,321	1,369	1,393	1,407	1,357	1,285	1,263	1,243	1,200	1,136	1,101	1,026	967	956	885	812	751	657
Cash Equivalents	510.8%	8.00	1.00	1.00	2.00	5.00	4.00	3.00	6.00	2.00	13.00	6.00	6.00	5.00	11.00	2.00	8.00	11.00	7.00	3.00	3.00	3.00
Goodwill	0%	6.00	6.00	6.00	6.00	6.00	6.00	6.00	6.00	6.00	6.00	6.00	6.00	6.00	6.00	6.00	6.00	-	-	-	-	-
Liabilities	0.7%	666	662	669	679	741	744	742	708	633	626	613	563	540	643	576	524	517	425	441	389	286
Shareholder's Equity	2.3%	597	584	611	641	628	633	665	649	653	638	630	637	596	458	449	443	439	460	371	362	371
Retained Earnings	-5.4%	-251	-238	-224	-213	-211	-198	-185	-179	-168	-157	-147	-138	-127	-116	-107	-88.04	-78.99	-71.39	-63.85	-57.40	-51.39
Additional Paid-In Capital	0.0%	723	722	722	722	722	722	722	722	720	711	700	700	649	505	487	463	440	433	340	323	322
Shares Outstanding	0.0%	66.00	66.00	66.00	66.00	66.00	66.00	65.00	65.00	65.00	61.00	64.00	61.00	-	-	-	-	-	-	-	-	-
Minority Interest	-0.5%	22.00	22.00	22.00	22.00	16.00	16.00	16.00	15.00	15.00	15.00	15.00	14.00	14.00	13.00	15.00	15.00	23.00	30.00	30.00	30.00	30.00
Float	-	-	-	-	564	-	-	-	693	-	-	-	892	-	-	-	481	-	-	-	324	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	-21.1%	14,293	18,125	16,666	17,878	15,771	18,308	18,314	23,483	16,436	17,283	18,608	17,789	15,287	16,131	-5,479	11,608	12,260	9,746	10,017	10,516	6,148
Share Based Compensation	0.9%	1,233	1,222	1,185	1,147	688	1,066	1,039	1,289	1,287	1,242	1,241	1,612	1,715	1,928	1,572	897	922	843	868	854	771
Cashflow From Investing	12.8%	-2,716	-3,114	5,664	61,974	3,092	-1,410	-33,448	-75,798	-26,596	-27,925	-50,769	-72,399	-43,572	-82,060	-65,653	-7,196	-68,763	-75,523	-65,200	-94,819	-22,655
Cashflow From Financing	34.0%	-10,495	-15,899	-24,503	-84,048	-19,337	-16,038	14,529	58,325	5,591	11,532	31,660	55,580	28,932	69,420	65,057	-7,951	66,194	67,136	55,137	86,867	14,972
Dividend Payments	-0.1%	1,455	1,456	1,455	1,456	1,455	1,456	1,455	1,456	1,455	1,456	1,455	1,456	1,455	1,456	1,455	-	2,911	1,457	1,454	1,456	1,455

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

GMRE Income Statement

2024-03-31

Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenue
Rental revenue	$ 35,069	$ 36,199
Other income	49	31
Total revenue	35,118	36,230
Expenses
General and administrative	4,446	3,804
Operating expenses	7,384	7,536
Depreciation expense	10,113	10,494
Amortization expense	3,971	4,395
Interest expense	6,890	8,271
Preacquisition expense		42
Total expenses	32,804	34,542
Income before gain on sale of investment property	2,314	1,688
Gain on sale of investment property		485
Net income	2,314	2,173
Less: Preferred stock dividends	(1,455)	(1,455)
Less: Net income attributable to noncontrolling interest	(65)	(45)
Net income (loss) attributable to common stockholders	$ 794	$ 673
Net income (loss) attributable to common stockholders per share - basic	$ 0.01	$ 0.01
Net income (loss) attributable to common stockholders per share - diluted	$ 0.01	$ 0.01
Weighted average shares outstanding - basic	65,573	65,525
Weighted average shares outstanding - diluted	65,573	65,525

GMRE Balance Sheet

2024-03-31

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Investment in real estate:
Land	$ 164,315	$ 164,315
Building	1,036,224	1,035,705
Site improvements	21,984	21,974
Tenant improvements	67,021	66,358
Acquired lease intangible assets	138,617	138,617
Investment in real estate, Total	1,428,161	1,426,969
Less: accumulated depreciation and amortization	(262,287)	(247,503)
Investment in real estate, net	1,165,874	1,179,466
Cash and cash equivalents	1,333	1,278
Restricted cash	6,473	5,446
Tenant receivables, net	7,743	6,762
Escrow deposits	737	673
Deferred assets	27,995	27,132
Derivative asset	29,285	25,125
Goodwill	5,903	5,903
Other Assets	17,874	15,722
Total assets	1,263,580	1,267,700
Liabilities:
Credit Facility, net of unamortized debt issuance costs of $6,518 and $7,067 at March 31, 2024 and December 31, 2023, respectively	592,082	585,333
Notes payable, net of unamortized debt issuance costs of $53 and $66 at March 31, 2024 and December 31, 2023, respectively	25,682	25,899
Accounts payable and accrued expenses	10,520	12,781
Dividends payable	16,157	16,134
Security deposits	4,376	3,688
Other liabilities	12,952	12,770
Acquired lease intangible liability, net	4,713	5,281
Total liabilities	666,482	661,886
Equity:
Preferred stock, $0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at March 31, 2024 and December 31, 2023, respectively (liquidation preference of $77,625 at March 31, 2024 and December 31, 2023, respectively)	74,959	74,959
Common stock, $0.001 par value, 500,000 shares authorized; 65,587 shares and 65,565 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively	66	66
Additional paid-in capital	722,623	722,418
Accumulated deficit	(251,963)	(238,984)
Accumulated other comprehensive income (loss)	29,285	25,125
Total Global Medical REIT Inc. stockholders' equity	574,970	583,584
Noncontrolling interest	22,128	22,230
Total equity	597,098	605,814
Total liabilities and equity	1,263,580	1,267,700
Related Party [Member]
Investment in real estate:
Due from related parties	363	193
Liabilities:
Other liabilities	$ 0	$ 0

About Global Medical REIT Inc

Global Medical REIT Inc. (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.

CEO	Mr. Jeffery M. Busch
WEBSITE	globalmedicalreit.com
INDUSTRY	REIT Mortgage
EMPLOYEES	29

Global Medical REIT Inc Frequently Asked Questions

What is the ticker symbol for Global Medical REIT Inc? What does GMRE stand for in stocks?

GMRE is the stock ticker symbol of Global Medical REIT Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Global Medical REIT Inc (GMRE)?

As of Fri May 17 2024, market cap of Global Medical REIT Inc is 584.39 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of GMRE stock?

You can check GMRE's fair value in chart for subscribers.

What is the fair value of GMRE stock?

You can check GMRE's fair value in chart for subscribers. The fair value of Global Medical REIT Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Global Medical REIT Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for GMRE so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Global Medical REIT Inc a good stock to buy?

The fair value guage provides a quick view whether GMRE is over valued or under valued. Whether Global Medical REIT Inc is cheap or expensive depends on the assumptions which impact Global Medical REIT Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for GMRE.

What is Global Medical REIT Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 17 2024, GMRE's PE ratio (Price to Earnings) is 26.71 and Price to Sales (PS) ratio is 4.18. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. GMRE PE ratio will change depending on the future growth rate expectations of investors.